(Q56944923)

English

Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: Experience from GUSTO-IIb

scientific article published on 01 January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

acute coronary syndrome

1 reference

based on heuristic

inferred from title

Paul W. Armstrong

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

9

object named as

R M Califf

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Christopher B. Granger

2

object named as

C B Granger

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Harvey D. White

3

object named as

H D White

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

N S Kleiman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D Ardissino

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

F V de Werf

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Zoldeyhi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

T D Thompson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

137

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

12-23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Incidence and follow-up of Braunwald subgroups in unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a 'new diagnostic mind-set'.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Thrombin activity and early outcome in unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Persistent activation of coagulation mechanism in unstable angina and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Comparison of heparin and aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970455-2

7 January 2021

Identifiers

10.1016/S0002-8703(99)70455-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878932%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56944923&oldid=2063428403"